Leigh MacMillan

April 5, 2018

Lung diseases share molecular signature

Lung diseases of infancy and aging share a molecular signature, pointing to a potential target for treatment and prevention.

By Leigh MacMillan
March 29, 2018

Nobel laureate Kobilka set to deliver Flexner Discovery Lecture on April 5

Brian Kobilka, MD, who shared the 2012 Nobel Prize in Chemistry for his studies of G protein-coupled receptors (GPCRs), will deliver the next Flexner Discovery Lecture on April 5.

By Leigh MacMillan
March 28, 2018

What protein is that?

An improved technology enables high-throughput protein identification in imaging mass spectrometry, aiding proteomics research.

By Leigh MacMillan
March 23, 2018

Voluntary exercise and energy balance

Non-exercise physical activity has a measurable energy expenditure, which goes down when animals engage in voluntary exercise, Vanderbilt researchers have discovered.

By Leigh MacMillan
March 22, 2018

Kidney disease imaging

Making multiple measurements with MRI can provide comprehensive information about the molecular and cellular changes caused by kidney injury.

By Leigh MacMillan
March 15, 2018

New imaging approach offers unprecedented views of staph infection

A new integrated imaging approach makes it possible to probe the molecules involved in invasive infections and can be broadly applied to any health or disease state.

By Leigh MacMillan
March 14, 2018

Botox for the shaky voice

Vanderbilt investigators found that Botox injection into the vocal cords can lead to improved quality of life for patients with voice muscle problems.
By Leigh MacMillan
March 13, 2018

Childhood tragedies forged a compassionate heart in Rhonda Ashley-Dixon

Her passion and dedication provide guidance to patients, families and providers at Vanderbilt Behavioral Health.
By Leigh MacMillan
March 9, 2018

Brain connections in schizophrenia

Brain imaging studies have implicated the connection between two brain regions in the pathophysiology of schizophrenia.
By Leigh MacMillan
March 1, 2018

Cancer immunotherapies expert Allison set for Discovery Lecture

James Allison, PhD, whose work led to the development of cancer immunotherapies known as “checkpoint inhibitors,” will deliver the next Flexner Discovery Lecture on Thursday, March 8.
By Leigh MacMillan
February 28, 2018

Structure of a stem cell niche

Understanding the specialized environment where stem cells reside is important for developing stem-cell based regenerative therapies.
By Leigh MacMillan
February 26, 2018

Cannabis compound reduces seizures

Cannabidiol (CBD) oils reduced seizures in patients with difficult-to-treat epilepsy, Vanderbilt investigators have found.
By Leigh MacMillan